PMID: 8584798Nov 1, 1995Paper

beta-Lactamases of Branhamella catarrhalis and their phenotypic implications

Research in Microbiology
E B ChaïbiJ F Acar

Abstract

Of the 50 strains of beta-lactamase-producing Branhamella catarrhalis isolated at Saint Joseph's Hospital (Paris) that were studied, 94% produced BRO-1 type beta-lactamase and 6% produced the BRO-2 type. We examined the transfer of BRO-1 and BRO-2 genes and found that, among 7 donor strains producing BRO-1, all were able to transfer the gene for BRO-1 production by conjugation. Of the 4 donor strains producing BRO-2, 2 were able to transfer the gene for BRO-2 production by conjugation. Three BRO-1 beta-lactamase-producing transformants were obtained from total DNA extracted from 3 strains producing BRO-1. Plasmid bands were demonstrated in strains of B. catarrhalis, but no change in plasmid profiles was seen in beta-lactamase-positive recombinants, supporting previous studies that suggested the beta-lactamases are chromosomal. In vitro activity of oral beta-lactams was tested for 67 strains of B. catarrhalis (56 beta-lactamase-producing strains). Cefixime, cefpodoxime and the combination ampicillin-clavulanic acid were very active against the beta-lactamase-producing strains. BRO-1 beta-lactamase appears to affect the activity of cefaclor, cefuroxime and loracarbef. BRO-2 beta-lactamases have no effect on the activity of these ...Continue Reading

References

Jul 1, 1977·The Journal of Antimicrobial Chemotherapy·B E MalmvallJ Johnsson
Sep 11, 1975·The Journal of Infectious Diseases·G M Thorne, W E Farrar
Apr 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I EliassonS G Waley
Jul 1, 1992·The Journal of Antimicrobial Chemotherapy·C P FungJ D Williams
Nov 1, 1991·The Journal of Antimicrobial Chemotherapy·J J ChristensenB Bruun
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·K Bush
Dec 1, 1986·Antimicrobial Agents and Chemotherapy·D R Schaberg, M J Zervos
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·E YokotaS Mitsuhashi
Feb 1, 1983·The Journal of Pediatrics·A L KovatchR H Michaels
Jan 1, 1983·Scandinavian Journal of Infectious Diseases·C KammeS Ståhl
Aug 1, 1983·The Journal of Antimicrobial Chemotherapy·I N Simpson, S J Plested
Jan 1, 1984·The Journal of Antimicrobial Chemotherapy·E E StobberinghC P van Boven
Jan 1, 1984·Scandinavian Journal of Infectious Diseases·C KammeS Ståhl
Mar 1, 1982·Antimicrobial Agents and Chemotherapy·T Farmer, C Reading
Jul 1, 1994·The Journal of Antimicrobial Chemotherapy·C P FungD M Livermore
Feb 1, 1994·The Journal of Antimicrobial Chemotherapy·C P FungD M Livermore

❮ Previous
Next ❯

Citations

Aug 26, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K McGregorT V Riley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.